Envoy Medical, Inc.

Envoy Medical, Inc., trading under the ticker ANZU, is a medical-device company that came to market through a special purpose acquisition company structure and operates in the healthcare sector with a focus on hearing-implant technology, specifically its Acclaim Totally Implantable Cochlear Implant system. The company's SPAC vehicle, ANZU Special Acquisition Corp, completed its initial public offering in 2021 and subsequently pursued a business combination with Envoy Medical as its target. The 10-Q filing dated May 16, 2022, with accession number 0001104659-22-061413, reflects the company's quarterly reporting obligations during its post-combination operating period. Envoy Medical targets patients with severe to profound hearing loss through a fully implanted device platform. For the complete filing history, transaction timeline, and real-time deal data on ANZU and hundreds of other SPACs, sign up for full access at SpacDesk.